Brain cancer drug Gleostine is no longer available for coverage under Medicare Part D after its seller, Miami-based NextSource Biotechnology, removed it from the program, according to The Wall Street Journal.
Payer
Through its multiple acquisitions, Humana is building a home-healthcare empire. Here are numbers to know:
Blue Cross and Blue Shield of Minnesota announced it has hired former U.S. Bank executive Matt Hunt to be the organization's first chief experience officer.
Pennsylvania Attorney General Josh Shapiro charged four Philadelphia business owners June 14 in connection to a $10 million Medicaid scam, according to The Philadelphia Inquirer.
Point32Health is the name of a new health insurance organization formed by the merger of Tufts Health Plan and Harvard Pilgrim Health Care.
UnitedHealthcare operates more than 1,500 accountable care agreements with providers, according to data in UnitedHealth Group's 2021 sustainability report.
Treating common conditions, including bronchitis and the flu, in primary care settings instead of emergency rooms could save health systems up to $320 billion over the next 10 years, according to UnitedHealth Group's 2020 Sustainability Report.
Civica Rx named the unit that will be tasked with lowering the cost of certain generic medicines, and said one of the nation's largest health insurers — Anthem — will join it.
Florida's largest autism services provider filed a complaint against the state's Medicaid program, alleging the new electronic visit-verification system being tested across eight counties is failing.
Medicare Advantage company Alignment Healthcare announced it will expand coverage to an additional 12 North Carolina counties in 2022, pending CMS' approval.
